Ready to play
Ready to play
A unique clinical trial in the world has shown that an antioxidant and anti-inflammatory drug can slow the progression of multiple sclerosis, fostering hope for the development of more effective treatments for this disease.
Notice: This Is an AI-Generated Summary
Comments (0)